Literature DB >> 23516009

Amlodipine-induced gingival hyperplasia in chronic renal failure: a case report.

N M Aldemir1, H Begenik, H Emre, F M Erdur, Y Soyoral.   

Abstract

Amlodipine is a dihydropyridine calcium channel blocker that is used in the management of both hypertension and angina. Amlodipine induced side effects are headache, dizziness, edema, flushing, palpitations, and rarely gingival hyperplasia. The exact reason of amlodipine-induced gingival hyperplasia is not known. We presented a case with chronic renal failure (CRF) that developed gingival hyperplasia due to amlodipine use, which improved after ceasing the drug.

Entities:  

Keywords:  Amlodipine; chronic renal failure; gingival hyperplasia

Mesh：

Substances：

Year:  2012        PMID： 23516009      PMCID： PMC3598305          DOI： 10.4314/ahs.v12i4.30

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN： 1680-6905            Impact factor:   0.927


  12 in total

Review 1.  Treatment of drug-induced gingival enlargement: aesthetic and functional considerations.

Authors:  P M Camargo; P R Melnick; F Q Pirih; R Lagos; H H Takei
Journal:  Periodontol 2000       Date:  2001       Impact factor: 7.589

2.  Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study.

Authors:  J S Ellis; R A Seymour; J G Steele; P Robertson; T J Butler; J M Thomason
Journal:  J Periodontol       Date:  1999-01       Impact factor: 6.993

Review 3.  The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts.

Authors:  W W Hallmon; J A Rossmann
Journal:  Periodontol 2000       Date:  1999-10       Impact factor: 7.589

Review 4.  Medically induced gingival hyperplasia.

Authors:  S J Meraw; P J Sheridan
Journal:  Mayo Clin Proc       Date:  1998-12       Impact factor: 7.616

5.  Prevalence of amlodipine-related gingival hyperplasia.

Authors:  M G Jorgensen
Journal:  J Periodontol       Date:  1997-07       Impact factor: 6.993

6.  Phenobarbital-induced gingival overgrowth? Report of two cases and complications in management.

Authors:  A P Gregoriou; P E Schneider; P R Shaw
Journal:  ASDC J Dent Child       Date:  1996 Nov-Dec

7.  Gingival sequestration of amlodipine and amlodipine-induced gingival overgrowth.

Authors:  J S Ellis; R A Seymour; J M Thomason; S C Monkman; J R Idle
Journal:  Lancet       Date:  1993-04-24       Impact factor: 79.321

Review 8.  The pharmacokinetic profile of amlodipine.

Authors:  D R Abernethy
Journal:  Am Heart J       Date:  1989-11       Impact factor: 4.749

9.  The clinical effects of nifedipine on periodontal status.

Authors:  S Tavassoli; N Yamalik; F Caglayan; G Caglayan; K Eratalay
Journal:  J Periodontol       Date:  1998-02       Impact factor: 6.993

10.  Incidence of verapamil-induced gingival hyperplasia in a dental population.

Authors:  C S Miller; D D Damm
Journal:  J Periodontol       Date:  1992-05       Impact factor: 6.993
View more
  3 in total

Review 1.  Oral manifestation in inflammatory bowel disease: a review.

Authors:  Kamran B Lankarani; Gholam Reza Sivandzadeh; Shima Hassanpour
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 2.  Drug-induced gingival overgrowth: A critical insight into case reports from over two decades.

Authors:  Pramod Samudrala; Vijay Kumar Chava; Tanguturi Sri Chandana; Rachakonda Suresh
Journal:  J Indian Soc Periodontol       Date:  2016 Sep-Oct

3.  Amlodipine-Induced Gingival Hyperplasia in a Young Male with Stage 5 Chronic Kidney Disease.

Authors:  Kevin John; Ajay Kumar Mishra; Karthik Gunasekaran; Ramya Iyyadurai
Journal:  Case Rep Nephrol       Date:  2020-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.